title: PTH stimulates the proliferation of TE-85 human osteosarcoma cells by a mechanism not involving either increased cAMP or increased secretion of IGF-I, IGF-II or TGF beta.
abstract: Injections of parathyroid hormone (PTH) result in increased bone formation in several species. Work in our laboratory and others has shown a stimulation of bone cell proliferation and growth factor production by PTH. Our purpose was to study the effects of PTH on a human bone cell line using TE-85 human osteosarcoma cells as a model. After 24 h treatment, PTH caused an increase in cell proliferation as measured by cell counts and [3H]-thymidine incorporation. Proliferation was not inhibited by an anti-transforming growth factor beta (TGF beta) antibody which could abolish stimulation by exogenous TGF beta. PTH did not stimulate cAMP production, alkaline phosphatase activity or production of insulin-like growth factors I or II (IGF-I or IGF-II) in TE-85 cells. Although basal TE-85 proliferation was slowed by incubation with the calcium channel blocking agent verapamil, PTH still caused an increase in growth rate. We conclude that PTH directly stimulates TE-85 proliferation via a mechanism not involving increased adenylate cyclase activity or increased secretion of IGF-I, IGF-II or TGF beta and may stimulate bone formation in vivo by activating some other mitogenic signal to increase bone cell proliferation.
authors.affiliation: Department of Periodontics, Loma Linda University, CA.
authors.forename: R D
authors.initials: RD
authors.lastname: Finkelman
authors.forename: S
authors.initials: S
authors.lastname: Mohan
authors.forename: T A
authors.initials: TA
authors.lastname: Linkhart
authors.forename: S M
authors.initials: SM
authors.lastname: Abraham
authors.forename: J P
authors.initials: JP
authors.lastname: Boussy
authors.forename: D J
authors.initials: DJ
authors.lastname: Baylink
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D000469:Alkaline Phosphatase / Q000378:metabolism; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D000242:Cyclic AMP / Q000378:metabolism*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D007335:Insulin-Like Growth Factor II / Q000378:metabolism*; D012516:Osteosarcoma / Q000201:enzymology / Q000473:pathology* / Q000503:physiopathology; D010281:Parathyroid Hormone / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D014700:Verapamil / Q000494:pharmacology
chemical_list: D010281:Parathyroid Hormone; D016212:Transforming Growth Factor beta; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II; D014700:Verapamil; D000242:Cyclic AMP; D000469:Alkaline Phosphatase; D000262:Adenylyl Cyclases